Olink

Olink®
Part of Thermo Fisher Scientific

Webinars

Discover innovation and expertise with our webinar series. Choose from three formats: Product Insights (learn about Olink’s products in depth), Application Focus (see how customers use Olink technology to advance their research), and Technical Proficiency (hosted by our expert support team with practical tips and strategies).

Featured WebinarsSearch webinars

Recent webinars

Watch the most recent Olink user presentations covering a range of topics including population-scale studies, Alzheimer’s reserach, and translational impact.

  • Application focus

    Decoding Immune Responses During and After Acute Malaria

    Explore why infection outcomes differ in this webinar on multi-omics in P. falciparum malaria. Learn how immune signatures link to severity, inflammation and prior exposure, and how proteomics with cellular profiling reveals host–pathogen interactions, immune regulation and memory.

    28 Oct 2026

    Learn More
  • Application focus

    Understanding cancer promotion and preventing pathologies of ageing

    Cancer is largely a disease of ageing. Oncogenic mutations build up in normal tissue over time, yet few mutant cell clones become cancer. Join our webcast to explore why some progress while others do not, and how inflammation may promote cancer.

    29 Oct 2026

    Learn More

More webinars

Full webinar library

Hear from industry leaders through webinars available whenever you need them.

Filters

Webinar
Application
Type
Products

Using NGS-Based Proteomics to Differentiate BTK Inhibitor Response in Leukemia

This webinar will highlight a study that compares the effect of three different BTK inhibitors: ibrutinib, acalabrutinib, and zanubrutinib. Patient samples were obtained before and at various time points after treatment to identify biomarkers that could be informative of the treatment’s effects.

Watch Now

Products

Immune-competent vascularized human cerebral organoids to study brain development and disease: a multiomics approach

The Network Biology Collaborative Centre at Mount Sinai Hospital, an Olink Certified Service Provider, present their application of Olink’s Proximity Extension Assay technology to profile an organoid-based model that provides novel regulatory and mechanistic insights into human brain development.

Watch Now

Products

Advancing proteomics in clinical research with the combined strengths of mass spectrometry and affinity-based methods

A roundtable discussion between key opinion leaders in proteomics explores how integrating antibody-based methods, like proximity extension assay (PEA), with LC-MS can expand proteome coverage, facilitate biomarker discovery, and streamline the validation process.

Watch Now

Charting the Future of Mental Health Precision Medicine with Proteomics

Results from a proteomics pilot study exploring biomarkers associated with postpartum depression (PPD) using Olink Explore HT. This research investigated a cohort of 50 mothers diagnosed with PPD, focusing on discovering proteins that may serve as unique biomarkers for early detection and treatment.

Watch Now

Products

Affinity Proteomics and LC-MS synergize Biomarker Discovery

Olink Certified Service Provider, Discovery Life Sciences, compares cutting-edge technology to study the proteome in liquid matrices.

Watch Now

Products

Integrating plasma proteomics to identify tuberculosis-specific diagnostic biomarkers

Using mass spectrometry, Olink’s proximity extension assay, cross-disciplinary research, and international collaboration, Dr. Schiff and team have identified protein biomarkers with high TB-specificity and demonstrated the diagnostic performance of a six-protein diagnostic panel.

Watch Now

Exploring molecular phenotypes of incident breast cancer through population-based proteogenomics

Anders Mälarstig, Director of Target Sciences at Pfizer, presents the integration of multi-omics for cancer prevention, large-scale proteomics analyses, and the use of high-throughput proteomics to identify actionable biomarkers for improved cancer diagnosis and treatment.

Watch Now

Products

What is a Good Biomarker?

Olink experts review the critical role of protein biomarkers in advancing personalized medicine, the challenges and opportunities of the protein biomarker development pipeline, and how PEA is facilitating the journey from discovery to clinical utility while delivering reproducible insights.

Watch Now

Products

Identifying Alzheimer's Disease Biomarkers: Insights for Diagnostics and Disease Monitoring

Explore advancements in blood-based biomarkers for Alzheimer’s disease in this webinar featuring Dr. Jason Jiang from the Hong Kong University of Science and Technology.

Register

Population-Level Multiomics for Precision Medicine

By analyzing samples from over 50,000 UK Biobank participants with Olink® Explore, Dr. Dhindsa's research revealed links between rare genetic variants and nearly 3,000 plasma proteins, providing new insights into disease biology and therapeutic target identification.

Watch Now

Products

Maternal inflammation during pregnancy and risk of immune-mediated diseases in birth cohorts

Jonathan Thorsen, MD Ph.D., Senior Researcher at COPSAC, presents a webinar on the HEDIMED project, which analyzed perinatal blood samples from four northern European birth cohorts to identify immune markers for childhood diseases, using the Olink Target96 Inflammation platform.

Watch Now

Products

Circulating inflammatory biomarkers associated with cognitive function and dementia

Dr. Margaret Doyle examines inflammation's role in cognitive decline and Alzheimer's using Olink proteomics, identifying key inflammatory biomarkers and their associations with cognitive domains in the Framingham Heart Study.

Watch Now

Products

Circulating inflammatory biomarkers associated with cognitive function and dementia

Dr. Margaret Doyle, Associate Professor of Pathology and Laboratory Medicine Department of Pathology and Laboratory Medicine Larner College of Medicine University of Vermont

Watch Now

Detecting Cancer Biomarkers from Proteins in Liquid Biopsies

Join Klaus Pantel, Chairman and Founding Director, Institute for Tumor Biology, and Christoffer Gebhardt, Head, university Skin Cancer Center, Hamburg, as they discuss the role of circulating protein biomarkers, technological advancements, and clinical applications in implementing liquid biopsy.

Watch Now

Products

Early detection of cancer risk biomarkers from the blood proteome

In this on-demand webinar, Dr. Karl Smith Byrne’s presented the results of a large Mendelian Randomization study that has identified several novel etiological markers of cancer risk from the blood proteome.

Watch Now

The right drug targets for the right patient – Using biomarkers to solve challenges in drug development

Dr. Jürgen Braunger of Boehringer Ingelheim Pharma, Dr. Timothy Radstake of AbbVie and Dr. Christopher D. Whelan of Biogen discuss clinical trials, current practices, historical context, and future challenges. Learn how protein markers enhance patient stratification by disease severity.

Watch Now

Products

Identification of predictive biomarkers of immunotherapy efficacy in cancer patients through analysis of plasma proteomics

Professor Antoine Italiano (Head of Early Phase Trials and Sarcoma Unit, Institut Bergonié) presents how protein biomarkers are providing an improve understanding and characterization of cancer patients stratification within Immuno-Oncology.

Watch Now

Products

Protein biomarkers in plasma: revealing biological insights into tumor microenvironment

This webinar explore how an extensive plasma proteomic analysis revealed biological insights about the tumor microenvironment in melanoma patients after immune checkpoint blockade and helped them to identify composite biomarkers to better predict sensitivity and response to immunotherapy.

Watch Now

Products

The Human Protein Atlas – implications for human biology, drug development and precision medicine

Professor Mathias Uhlén presents the groundbreaking Human Protein Atlas (HPA) program, which integrates proteomics, transcriptomics, and AI-based systems biology to map human proteins. Learn how this open-access resource informs drug development and precision medicine.

Watch Now

Products

Driving Next-generation medicine discovery: exposing causal biomarker-disease relationships using proteomics

Speakers from SCALLOP discuss how enabling technologies are allowing proteogenomic studies to be performed on a scale not previously possible, and will provide examples of such studies, including one assessing links between angiotensin-converting enzyme 2 (ACE2) expression and COVID-19.

Watch Now

Products

66 webinars